BRPI0509881A - therapeutic combination for treatment of alzheimer's disease - Google Patents
therapeutic combination for treatment of alzheimer's diseaseInfo
- Publication number
- BRPI0509881A BRPI0509881A BRPI0509881-5A BRPI0509881A BRPI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- alzheimer
- treatment
- therapeutic combination
- treating alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
COMBINAçãO TERAPêUTICA PARA TRATAMENTO DA DOENçA DE ALZHEIMER. A presente invenção refere-se a composições farmacêuticas úteis para tratar a Doença de Alzheimer. Também são descritos métodos para tratar a Doença de Alzheimer.THERAPEUTIC COMBINATION FOR TREATMENT OF ALZHEIMER'S DISEASE. The present invention relates to pharmaceutical compositions useful for treating Alzheimer's disease. Also described are methods for treating Alzheimer's disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56214104P | 2004-04-14 | 2004-04-14 | |
PCT/IB2005/000923 WO2005099823A1 (en) | 2004-04-14 | 2005-04-04 | Therapeutic combination for treatment of alzheimers disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509881A true BRPI0509881A (en) | 2007-10-16 |
Family
ID=34963723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509881-5A BRPI0509881A (en) | 2004-04-14 | 2005-04-04 | therapeutic combination for treatment of alzheimer's disease |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1737539A1 (en) |
JP (1) | JP2007532624A (en) |
KR (1) | KR20060133008A (en) |
CN (1) | CN1960781A (en) |
AU (1) | AU2005232447A1 (en) |
BR (1) | BRPI0509881A (en) |
CA (1) | CA2562069A1 (en) |
IL (1) | IL178120A0 (en) |
MX (1) | MXPA06011969A (en) |
NO (1) | NO20065196L (en) |
RU (1) | RU2006136361A (en) |
TW (1) | TW200533341A (en) |
WO (1) | WO2005099823A1 (en) |
ZA (1) | ZA200608239B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI432195B (en) | 2007-10-03 | 2014-04-01 | Kowa Co | Nerve cell death inhibiting agent |
EP3413870B1 (en) * | 2016-02-11 | 2021-08-04 | SigmaThera SAS | Igmesine for use in the treatment of alzheimer's disease |
WO2020252475A1 (en) * | 2019-06-14 | 2020-12-17 | Atiba Joshua O | Triple pharmaceutical composition for proteinaceous infection |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
KR100986194B1 (en) * | 2002-04-02 | 2010-10-07 | 얀센 파마슈티카 엔.브이. | Statin therapy for enhancing cognitive maintenance |
AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
EP1585520A1 (en) * | 2002-12-24 | 2005-10-19 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | Method and composition for treating neurodegenerative disorders |
JP2006520368A (en) * | 2003-03-19 | 2006-09-07 | アレス トレーディング ソシエテ アノニム | Treatment of Alzheimer's disease |
US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-04-04 AU AU2005232447A patent/AU2005232447A1/en not_active Abandoned
- 2005-04-04 MX MXPA06011969A patent/MXPA06011969A/en unknown
- 2005-04-04 BR BRPI0509881-5A patent/BRPI0509881A/en not_active IP Right Cessation
- 2005-04-04 EP EP05718393A patent/EP1737539A1/en not_active Withdrawn
- 2005-04-04 CN CNA2005800173902A patent/CN1960781A/en active Pending
- 2005-04-04 WO PCT/IB2005/000923 patent/WO2005099823A1/en active Application Filing
- 2005-04-04 JP JP2007507862A patent/JP2007532624A/en not_active Withdrawn
- 2005-04-04 CA CA002562069A patent/CA2562069A1/en not_active Abandoned
- 2005-04-04 KR KR1020067021174A patent/KR20060133008A/en not_active Application Discontinuation
- 2005-04-04 RU RU2006136361/15A patent/RU2006136361A/en not_active Application Discontinuation
- 2005-04-13 TW TW094111657A patent/TW200533341A/en unknown
-
2006
- 2006-09-14 IL IL178120A patent/IL178120A0/en unknown
- 2006-10-03 ZA ZA200608239A patent/ZA200608239B/en unknown
- 2006-11-13 NO NO20065196A patent/NO20065196L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007532624A (en) | 2007-11-15 |
CA2562069A1 (en) | 2005-10-27 |
IL178120A0 (en) | 2006-12-31 |
TW200533341A (en) | 2005-10-16 |
ZA200608239B (en) | 2008-06-25 |
RU2006136361A (en) | 2008-04-20 |
EP1737539A1 (en) | 2007-01-03 |
NO20065196L (en) | 2007-01-03 |
AU2005232447A1 (en) | 2005-10-27 |
MXPA06011969A (en) | 2006-12-15 |
KR20060133008A (en) | 2006-12-22 |
CN1960781A (en) | 2007-05-09 |
WO2005099823A1 (en) | 2005-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901373A1 (en) | AMINOGETEROCYCLIC COMPOUNDS | |
ATE475650T1 (en) | POSITIVE ALLOSTERIC QUINOLONE M1 RECEPTOR MODULATORS | |
ECSP055719A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
BR0315158A (en) | Pyrazole Compounds for the Treatment of Neurodegenative Disorders | |
BR0316350A (en) | Diaminotriazoles useful as protein kinase inhibitors | |
BRPI0413245A (en) | 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders | |
DOP2005000040A (en) | IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
EP1841426A4 (en) | Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease | |
ATE530544T1 (en) | BENZYL-SUBSTITUTED POSITIVE ALLOSTERIC QUINOLONE M1 RECEPTOR MODULATORS | |
BRPI0407662B8 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
EA200801481A1 (en) | 5- (AROSULFONYL) PYRAZOLOPIPERIDES | |
WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
UY30377A1 (en) | FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA | |
EP1817312A4 (en) | Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
BRPI0509477A (en) | sulfonamide compounds for the treatment of neurodegenerative disorders | |
EA200600971A1 (en) | APPLICATION OF SUBSTITUTED 2 - AMINOTHETRALINES FOR THE PREVENTION TREATMENT OF PARKINSON'S Disease | |
BRPI0413709A (en) | compounds for the treatment of neurodegenerative disorders | |
BR0316723A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
ATE409480T1 (en) | PYRAZOLOA3,4-BUPYRIDINE-6-ONE AS GSK-3 INHIBITORS | |
CY1110401T1 (en) | PRODUCTION OF 1-PHENYLCOCARCAROXYLIC ACIDS FOR TREATMENT OF NEUROCOLOGICAL DISEASES | |
ATE371724T1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
PT1778837E (en) | Treatment of neurodegenerative diseases by the use of scd4 inhibitors | |
BRPI0509881A (en) | therapeutic combination for treatment of alzheimer's disease | |
EA200501865A1 (en) | ANALOGUES OF TIOVOLFRAMATOV AND THEIR APPLICATION | |
BRPI0514303A (en) | pharmaceutical composition and method for treating neurodegenerative disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/445 (2006.01), A61P 25/28 (2006.01), A61K |